Antioxidants 8:384
they increase susceptibility to secondary infections such as coccidiosis, necrotic enteritis, salmonellosis and many others
Importantly, tirzepatide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in people with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
FDA has released its briefing materials for the meeting, published its current position on the substances under review, updated the meeting schedule, and announced that another peptide-focused PCAC meeting will take place before the end of February 2027
CE Information: Center for Change has been approved by NBCC as an Approved Continuing Education Provider, ACEP No
Benson J, Marais M, Flanigan P